SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas Kirwin who wrote (34)3/11/1998 11:30:00 PM
From: Mason Barge   of 422
 
I've heard a couple of people speculate about this from time to time (not the current J&J rumor, that's news to me) and my reaction is disdain. Immucor has spend two years doing the pre-marketing for the ABS series and I don't want my massive gains diluted by an acquisition. The company management is quite sound and I think they can make more money -- and a higher share price -- by themselves. Because of the extensive inside ownership, though, I have some degree of faith that there won't be a takeover unless managment thinks the terms are favorable

In other words, if the ABS 2000 is approved, I'm not selling my Immucor for $20 a share. I think it will be worth more. In fact, if we're lucky, some big momentum players will get involved and drive the price up into the 30's.

Your greedy amigo, Mason
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext